Eli Lilly Company Operations Pain Relief Sanofi Paracetamol Paracetamol Production Weight-loss Treatments Blood Plasma Products Controlled Substances Japanese Drugmakers Pricing Strategies Global Trade Legal Issues Novo Nordisk Tariffs
The company surpassed analyst expectations, reaffirmed 2025 guidance, and outlined strategies to mitigate tariff impacts while navigating mixed portfolio performance.